Bexmarilimab continues to show strong efficacy in phase 1/2 trial update

Updated results from a phase 1/2 trial of bexmarilimab plus azacitidine continue to support the efficacy of the combination in.

by Leah Sherwood
October 21, 2025

SOHO MENA returns to in-person meeting for region’s 3rd meeting

SOHO Insider Editors October 20, 2025

Now in its third year, the meeting featured a comprehensive program covering all blood cancers, bringing together world-class clinicians including Drs. Hagop Kantarjian, Courtney DiNardo, Elias Jabbour, Naval Daver, Rami Komrokji, and Amer Zeidan for lively discussions and exchange of ideas.

Read More ➔

Improving Outcomes in CHIP/CCUS with Dr. Borate

SOHO Insider Editors October 20, 2025

This Meet the Professor session was delivered by Uma Borate, MD, MS, an associate professor at the Ohio State University Comprehensive Cancer Center, at SOHO 2025.

Read More ➔

VERONA phase 3 trial shows no survival benefit in high-risk MDS

Leah Sherwood October 18, 2025

The study, presented by Guillermo Garcia-Manero, MD, interim chair of the Department of Leukemia at the University of Texas MD Anderson Cancer Center, evaluated the efficacy and safety of venetoclax in combination with azacitidine in treatment-naive patients with high-risk MDS.

Read More ➔

Drs. Jabbour, Logan, and Aldoss discuss treatment advancements in ALL

SOHO Insider Editors October 17, 2025

In this panel discussion at the Thirteenth Annual Meeting of the Society of Hematologic Oncology (SOHO 2025), Elias Jabbour, MD, leukemia professor at the University of Texas MD Anderson Cancer Center, moderates a discussion on acute lymphoblastic leukemia (ALL) treatment with Aaron Logan, MD, PhD, from the University of California, San Francisco, and Ibrahim T. Aldoss, MD, from the City of Hope.

Read More ➔

Sagar Lonial, MD, on what to expect at SOHO Breakthroughs in Blood Cancers

Leah Sherwood October 17, 2025

Society of Hematologic Oncology Insider news

Sagar Lonial, MD, on what to expect at SOHO Breakthroughs in Blood Cancers

00:00 / 1:40

Sagar Lonial, MD, and Saad Usmani, MD, provide a sneak peek on what attendees can expect to learn at SOHO Breakthroughs in Blood Cancers (SBBC). Dr. Lonial will be the presenter of the myeloma session at the meeting. His talk is scheduled for 1:35 pm Central time on November 20, 2025.

Read More ➔